Federal Register / Vol. 74, No. 17 / Wednesday, January 28, 2009 / Notices 4963 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Indian Health Service 

Request for Public Comment: 60-Day 

Proposed Information Collection: 

Indian Health Service Director’s Three 

Initiative Best Practice, Promising 

Practice, and Local Effort Form 

AGENCY: Indian Health Service, HHS. 

ACTION: Notice. 

SUMMARY: In compliance with Section 

3506(c)(2)(A) of the Paperwork 

Reduction Act of 1995 which requires 

60 days for public comment on 

proposed information collection 

projects, the Indian Health Service (IHS) 

is publishing for comment a summary of 

a proposed information collection to be 

submitted to the Office of Management 

and Budget (OMB) for review. 

Proposed Collection: Title: 0917– 

NEW, ‘‘Indian Health Service Director’s 

Three Initiative Best Practice, Promising 

Practice, and Local Effort Form.’’ Type 

of Information Collection Request: 

Three year approval of this new 

information collection, 0917–NEW, 

‘‘Indian Health Service Director’s Three 

Initiative Best Practice, Promising 

Practice, and Local Effort (BPPPLE) 

Form.’’ 

Form(s): The Indian Health Service 

BPPPLE form. Need and Use of 

Information Collection: The Indian 

Health Service (IHS) goal is to raise the 

health status of the American Indian 

and Alaska Native (AI/AN) people to the 

highest possible level by providing 

comprehensive health care and 

preventive health services. To support 

the HiS mission, the Director’s Three 

Initiative was launched which is 

comprised of Health Promotion and 

Disease Prevention (HP/DP), Behavioral 

Health (BH) and Chronic Care (CC). The 

Director’s Three Initiative is linked 

together in their aim to reduce health 

disparities and improve the health and 

wellness among the AI/AN populations 

through a coordinated and systematic 

approach to enhance health promotion, 

and chronic disease and mental health 

prevention methods at the local, 

regional, and national levels. 

To provide the product/service to 

IHS, Tribal, and Urban (I/T/U) 

programs, the Director’s Three Initiative 

work together to develop a centralized 

program database of Best/Promising 

Practices (BPP). The purpose of this 

collection is to develop a database of 

BPP to be published on the IHS.gov Web 

site which will be a resource for 

program evaluation and for modeling 

examples of HP/DP, BH, and CC projects 

occurring in AI/AN communities. 

This is a request that OMB approves, 

under the Paperwork Reduction Act, an 

IHS information collection initiative to 

promote submission of ‘‘Best and 

Promising Practices and Local Efforts’’ 

among the I/T/U. 

All information submitted is on a 

voluntary basis; no legal basis exists for 

collection of this information. 

The information collected will enable 

the Director’s Three Initiative program 

to: (a) Identify evidence based 

approaches to prevention programs 

among the I/T/U when no system is 

currently in place; and (b) Allow the 

program managers to review BPPPLE 

occurring among the I/T/U when 

considering program planning for their 

community. 

Affected Public: Individuals. Type of 

Respondents: I/T/U organizations 

program staff. 

The table below provides: Types of 

data collection instruments, Number of 

respondents, Responses per respondent, 

Average burden hour per response, and 

Total annual burden hour(s). 

Estimated Burden Hours 

Data collection instrument(s) Number of 

respondents 

Responses 

per 

respondent 

Average 

burden hour 

per response 

Total annual 

burden hours 

IHS Service Unit, Tribal, and Urban Indian Center Administrators ................. 100 1 20/60 33.3 

Total .......................................................................................................... 100 ........................ ........................ 33.3 

There are no Capital Costs, Operating 

Costs, and/or Maintenance Costs to 

report. 

Request for Comments: Your written 

comments and/or suggestions are 

invited on one or more of the following 

points: (a) Whether the information 

collection activity is necessary to carry 

out an agency function; (b) whether the 

agency processes the information 

collected in a useful and timely fashion; 

(c) the accuracy of the public burden 

estimate (the estimated amount of time 

needed for individual respondents to 

provide the requested information); (d) 

whether the methodology and 

assumptions used to determine the 

estimates are logical; (e) ways to 

enhance the quality, utility, and clarity 

of the information being collected; and 

(f) ways to minimize the public burden 

through the use of automated, 

electronic, mechanical, or other 

technological collection techniques or 

other forms of information technology. 

Send Comments and Requests for 

Further Information: Send your written 

comments, requests for more 

information on the proposed collection, 

or requests to obtain a copy of the data 

collection instrument(s) and 

instructions to: Ms. Betty Gould, 

Regulations Officer, 801 Thompson 

Avenue, TMP, Suite 450, Rockville, MD 

20852–1627; call (301) 443–7899; send 

via facsimile to (301) 443–9879; or send 

your e-mail requests, comments, and 

return address to: betty.gould@ihs.gov. 

Comment Due Date: Your comments 

regarding this information collection are 

best assured of having full effect if 

received within 60 days of the date of 

this publication. 

Dated: January 21, 2009. 

Robert G. McSwain, 

Director, Indian Health Service. 

[FR Doc. E9–1794 Filed 1–27–09; 8:45 am] 

BILLING CODE 4165–16–M 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Fogarty International Center; Notice of 

Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. Appendix 2), notice 

is hereby given of a meeting of the 

Fogarty International Center Advisory 

Board. 

The meeting will be open to the 

public as indicated below, with 

attendance limited to space available. 

Individuals who plan to attend and 

need special assistance, such as sign 

language interpretation or other 

reasonable accommodations, should 

notify the Contact Person listed below 

in advance of the meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 


sroberts on PROD1PC70 with NOTICES
4964 Federal Register / Vol. 74, No. 17 / Wednesday, January 28, 2009 / Notices 

as amended. The grant applications 

and/or contract proposals and the 

discussions could disclose confidential 

trade secrets or commercial property 

such as patentable material, and 

personal information concerning 

individuals associated with the grant 

applications and/or contract proposals, 

the disclosure of which would 

constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: Fogarty International 

Center Advisory Board. 

Date: February 9–10, 2009. 

Closed: February 9, 2009, 1 p.m. to 3 p.m. 

Agenda: To review and evaluate grant 

applications and/or proposals. 

Place: National Institutes of Health, 

Lawton Chiles International House, Bethesda, 

MD 20892. 

Closed: February 10, 2009, 8:30 a.m. to 

10:30 a.m. 

Agenda: To review and evaluate grant 

applications and/or proposals. 

Place: National Institutes of Health, 

Lawton Chiles International House, Bethesda, 

MD 20892. 

Open: February 10, 2009, 10:30 a.m. to 5 

p.m. 

Agenda: Topics of the meeting include: (1) 

The implementation of the FIC Strategic 

Plan; (2) FIG regional priorities; (3) the role 

of U.S. diplomatic priorities in planning 

global programs; and (4) priorities for publicprivate partnerships. 

Place: National Institutes of Health, 

Lawton Chiles International House, Bethesda, 

MD 20892. 

Contact Person: Robert Eiss, Public Health 

Advisor, Fogarty International Center, 

National Institutes of Health, 31 Center Drive, 

Room B2C02, Bethesda, MD 20892, (301) 

496–1415, EISSR@MAIL.NIH.GOV. 

This meeting is being published less than 

15 days prior to the meeting due to timing 

limitations imposed by administrative 

matters. 

Any interested person may file written 

comments with the committee by forwarding 

the statement to the Contact Person listed on 

this notice. The statement should include the 

name, address, telephone number and when 

applicable, the business or professional 

affiliation of the interested person. 

In the interest of security, NIH has 

instituted stringent procedures for entrance 

onto the NIH campus. All visitor vehicles, 

including taxicabs, hotel, and airport shuttles 

will be inspected before being allowed on 

campus. Visitors will be asked to show one 

form of identification (for example, a 

government-issued photo ID, drivers license, 

or passport) and to state the purpose of their 

visit. 

Information is also available on the 

Institute’s/Center’s home page: http:// 

www.nih.gov/fic/about/advisory.html, where 

an agenda and any additional information for 

the meeting will be posted when available. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.106, Minority International 

Research Training Grant in the Biomedical 

and Behavioral Sciences; 93.154, Special 

International Postdoctoral Research Program 

in Acquired lmmunodeficiency Syndrome; 

93.168, International Cooperative 

Biodiversity Groups Program; 93.934, Fogarty 

International Research Collaboration Award; 

93.989, Senior International Fellowship 

Awards Program, National Institutes of 

Health, HHS) 

Dated: January 21, 2009. 

Jennifer Spaeth, 

Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. E9–1753 Filed 1–27–09; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute of Allergy and 

Infectious Diseases; Notice of Closed 

Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. Appendix 2), notice 

is hereby given of the following 

meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Institute of 

Allergy and Infectious Diseases Special 

Emphasis Panel; Bacillus Anthracis Program 

Project. 

Date: February 19, 2009. 

Time: 12 a.m. to 4 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6700- 

B Rockledge Drive, Room 3122, Bethesda, 

MD 20817, (Telephone Conference Call). 

Contact Person: Brenda Lange-Gustafson, 

PhD, Scientific Review Officer, NIAID/NIH/ 

DHHS, Scientific Review Program, Room 

3122, 6700-B Rockledge Drive, MSC–7616, 

Bethesda, MD 20892–7616, 301–451–3684, 

bgustafson@niaid.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.855, Allergy, Immunology, 

and Transplantation Research; 93.856, 

Microbiology and Infectious Diseases 

Research, National Institutes of Health, HHS) 

Dated: January 22, 2009. 

Jennifer Spaeth, 

Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. E9–1856 Filed 1–27–09; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute of Diabetes and 

Digestive and Kidney Diseases; Notice 

of Closed Meetings 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. Appendix 2), notice 

is hereby given of the following 

meetings. 

The meetings will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Institute of 

Diabetes and Digestive and Kidney Diseases 

Special Emphasis Panel; Eicosanoids in 

Renal Function Program Projects. 

Date: March 3, 2009. 

Time: 1 p.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, Two 

Democracy Plaza, 6707 Democracy 

Boulevard, Bethesda, MD 20892, (Telephone 

Conference Call). 

Contact Person: Atul Sahai, PhD, Scientific 

Review Officer, Review Branch, DEA, 

NIDDK, National Institutes of Health, Room 

759, 6707 Democracy Boulevard, Bethesda, 

MD 20892–5452, (301) 594–2242, 

sahaia@niddk.nih.gov. 

Name of Committee: National Institute of 

Diabetes and Digestive and Kidney Diseases 

Special Emphasis Panel; Trafficking in 

Polarized Epithelial Cells. 

Date: April 7, 2009. 

Time: 8 a.m. to 2 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Bethesda Marriott Suites, 6711 

Democracy Boulevard, Bethesda, MD 20817. 

Contact Person: Maria E. Davila-Bloom, 

PhD, Scientific Review Officer, Review 

Branch, DEA, NIDDK, National Institutes of 

Health, Room 758, 6707 Democracy 

Boulevard, Bethesda, MD 20892–5452, (301) 

594–7637, davila-bloomm@niddk.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.847, Diabetes, 

Endocrinology and Metabolic Research; 

93.848, Digestive Diseases and Nutrition 

Research; 93.849, Kidney Diseases, Urology 

and Hematology Research, National Institutes 

of Health, HHS) 


sroberts on PROD1PC70 with NOTICES